Novo Seeds builds innovative biotech companies in Europe primarily through early-stage investment. In close collaboration with leading researchers, academic institutions, entrepreneurs and leaders in the biotech industry, we help promising life science develop its commercial potential through two programmes: pre-seed grants and investments.
Novo Seeds is part of Novo A/S, the holding company in the Novo Group with more than 300bn DKK under management.
Roche Venture fund
Lundbeckfonden Emerge is the early stage investment unit of Lundbeckfonden, one of the largest industrial foundations in Denmark with a market value of more than DKK 50 billion. In addition to the three subsidiaries, Lundbeck, ALK-Abelló and Falck, the Foundation manages a portfolio of more than 20 life science investments in Europe and the US.
CAPNOVA is a publicly funded pre-seed investor and entrepreneur development house, with 100+ startups under management financing excellent teams with high potential entrepreneurs.
CAPNOVA covers Denmark with offices in Aarhus, Roskilde and Copenhagen.